======= VPS53 ======= == Gene Information == * **Official Symbol**: VPS53 * **Official Name**: VPS53 subunit of GARP complex * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55275|55275]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5VIR6|Q5VIR6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VPS53&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VPS53|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615850|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein with sequence similarity to the yeast Vps53p protein. Vps53p is involved in retrograde vesicle trafficking in late Golgi. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Acts as component of the GARP complex that is involved in retrograde transport from early and late endosomes to the trans-Golgi network (TGN). The GARP complex is required for the maintenance of the cycling of mannose 6-phosphate receptors between the TGN and endosomes, this cycling is necessary for proper lysosomal sorting of acid hydrolases such as CTSD (PubMed:15878329, PubMed:18367545). Acts as component of the EARP complex that is involved in endocytic recycling. The EARP complex associates with Rab4-positive endosomes and promotes recycling of internalized transferrin receptor (TFRC) to the plasma membrane (PubMed:25799061). {ECO:0000269|PubMed:15878329, ECO:0000269|PubMed:18367545, ECO:0000269|PubMed:25799061}. |DUF2450| |Vps53 N| |GARP complex| |EARP complex| |endocytic recycling| |trans-Golgi network membrane| |retrograde transport, endosome to Golgi| |lysosomal transport| |recycling endosome| |vacuolar transport| |cytosolic transport| |endosome membrane| |endosomal transport| |perinuclear region of cytoplasm| |Golgi apparatus| |protein transport| |intracellular transport| |peptide transport| |amide transport| |establishment of protein localization| |establishment of localization in cell| |nitrogen compound transport| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-2.26| |[[:results:exp376|Losmapimod 1μM R07 exp376]]|-2.2| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.18| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-2.06| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-2.02| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-2.02| |[[:results:exp443|SNS-032 15μM R08 exp443]]|-2| |[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|-1.98| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.95| |[[:results:exp401|SNS-032 25μM R07 exp401]]|-1.93| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-1.92| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.87| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|-1.86| |[[:results:exp211|AICAR 240μM R05 exp211]]|-1.85| |[[:results:exp262|Alda-1 10μM R06 exp262]]|-1.84| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-1.81| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.78| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-1.78| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-1.75| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|-1.74| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.74| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|-1.72| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|-1.7| |[[:results:exp93|DABN racemic mixture R03 exp93]]|-1.7| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|1.88| ^Gene^Correlation^ |[[:human genes:v:vps28|VPS28]]|0.46| |[[:human genes:r:rrp9|RRP9]]|0.406| |[[:human genes:t:trappc11|TRAPPC11]]|0.404| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1015 * **Expression level (log2 read counts)**: 6.39 {{:chemogenomics:nalm6 dist.png?nolink |}}